Yuyu Pharma Inc. (000227) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yuyu Pharma Inc. (000227:KRX), powered by AI.

Current Price
₩10,610
P/E Ratio
0.4
Market Cap
3.5B
Sector
Healthcare
What is the Yuyu Pharma Inc. stock price forecast?

Yuyu Pharma Inc. is currently trading at ₩10,610. View real-time AI analysis on Alpha Lenz.

What is Yuyu Pharma Inc. insider trading activity?

View the latest insider trading data for Yuyu Pharma Inc. on Alpha Lenz.

What is Yuyu Pharma Inc.'s P/E ratio?

Yuyu Pharma Inc.'s P/E ratio is 0.4.

Yuyu Pharma Inc.

KRX · 000227
₩10,610-10(-0.09%)Market closedKRX regular session 09:00–15:30 KST
Ask about Yuyu Pharma Inc.'s future dividend policy...
Alpha Chat Insight

Yuyu Pharma Inc. trades at a P/E of 0.4 (undervalued) with modest ROE of 6.4%.

Ask for details

Company Overview

Yuyu Pharma Inc. is a prominent pharmaceutical company, primarily engaged in the development, manufacture, and distribution of medical products, specifically focusing on pharmaceuticals and health supplements. The company's core mission is to improve health outcomes by offering innovative and effective therapeutic solutions. Yuyu Pharma Inc. plays a significant role in the healthcare sector, particularly in the areas of cardiovascular, metabolic, and central nervous system disorders. Additionally, the company's product lineup includes both prescription and over-the-counter medications, catering to diverse medical needs. This diversification allows Yuyu Pharma to address various market demands and remain resilient amidst changing industry dynamics. Headquartered in South Korea, Yuyu Pharma Inc. has established a significant presence in both domestic and international markets, leveraging its research and development capabilities to stay competitive within the global pharmaceutical industry. Its consistent focus on quality and innovation underscores its strategic importance in the health and wellness domains, contributing actively to advancements in medical treatments and patient care across regions.

CEOMr. Wonsang Yu
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees254

Company Statistics

FY 2025

Profile

₩3,454,191,600Market Cap
₩140,884,666,970Revenue
325.56KShares Out
254Employees

Margins

38.29%Gross
12.10%EBITDA
7.82%Operating
6.73%Pre-Tax
6.47%Net

Valuation

0.42P/E
0.03P/B
0.02EV/Sales
0.77EV/EBITDA
0.47P/FCF

Growth (CAGR)

0.48%Rev 3Yr
7.50%Rev 5Yr
N/AOp Inc 3Yr
11.93%Op Inc 5Yr
N/ANet Inc 3Yr
30.46%Net Inc 5Yr

Returns

4.39%ROA
6.40%ROE
5.77%ROIC

Financial Health

₩29,090,832,970Cash & Cash Equivalents
₩37,588,392,430Net Debt
47.44%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Yuyu Pharma Inc. (ticker: 000227) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 254 employees. Market cap is $3.5B.

The current price is ₩10,610 with a P/E ratio of 0.42x and P/B of 0.03x.

ROE is 6.40% and operating margin is 7.82%. Annual revenue is $140.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Yuyu Pharma Inc. (000227) Stock Forecast 2026 ₩10,610 — Price, Financials & Analyst Targets | Alpha Lenz